Fibrin conduit supplemented with human mesenchymal stem cells and immunosuppressive treatment enhances regeneration after peripheral nerve injury

Neuroscience Letters

Volumn 516, Issue 2, 2012, Pages 171-176

  McGrath, Aleksandra M ^a   Brohlin, Maria ^a   Kingham, Paul J ^a   Novikov, Lev N ^a   Wiberg, Mikael ^a   Novikova, Liudmila N ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Bone marrow; Mesenchymal stem cells; Nerve conduit; Peripheral nerve injury; Regeneration

Indexed keywords

CYCLOSPORIN A; FIBRIN GLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL LABELING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MESENCHYMAL STEM CELL; NERVE FIBER REGENERATION; NERVE GRAFT; NERVE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE INJURY;

ANIMALS; AXOTOMY; BIOCOMPATIBLE MATERIALS; BIOENGINEERING; CYCLOSPORINE; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE REGENERATION; PERIPHERAL NERVE INJURIES; PROSTHESES AND IMPLANTS; RATS; RATS, INBRED F344; SCIATIC NERVE;

EID: 84860480168     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.041     Document Type: Article

References (37)

1. Atoui R., Asenjo J.F., Duong M., Chen G., Chiu R.C., Shum-Tim D. Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance. Ann. Thorac. Surg. 2008, 85:571-579.
2. Atoui R., Shum-Tim D., Chiu R.C. Myocardial regenerative therapy: immunologic basis for the potential universal donor cells. Ann. Thorac. Surg. 2008, 86:327-334.
3. Bensaid W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003, 24:2497-2502.
4. Bianchi R., Rodella L., Rezzani R. Cyclosporine A up-regulates expression of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart. Int. Immunopharmacol. 2003, 427-433.
5. Bini A., Itoh Y., Kudryk B.J., Nagase H. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Biochemistry 1996, 13056-13063.
6. Brohlin M., Mahay D., Novikov L.N., Terenghi G., Wiberg M., Shawcross S.G., Novikova L.N. Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci. Res. 2009, 64:41-49.
7. Chalfoun C.T., Wirth G.A., Evans G.R. Tissue engineered nerve constructs: where do we stand?. J. Cell. Mol. Med. 2006, 10:309-317.
8. de Ruiter G.C., Malessy M.J., Yaszemski M.J., Windebank A.J., Spinner R.J. Designing ideal conduits for peripheral nerve repair. Neurosurg. Focus 2009, 26:E5.
9. Ghannam S., Bouffi C., Djouad F., Jorgensen C., Noël D. Immunosuppresion by mesenchymal stem cells; mechanisms and clinical applications. Stem Cell Res. Ther. 2010, 1(1):2.
10. Gillon R.S., Cui Q., Dunlop S.A., Harvey A.R. Effects of immunosuppression on regrowth of adult rat retinal ganglion cell axons into peripheral nerve allografts. J. Neurosci. Res. 2003, 74:524-532.
11. Grinnemo K.H., Mansson A., Dellgren G., Klingberg D., Wardell E., Drvota V., Tammik C., Holgersson J., Ringden O., Sylven C., Le B.K. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 2004, 127:1293-1300.
12. Grinnemo K.H., Mansson-Broberg A., Leblanc K., Corbascio M., Wardell E., Siddiqui A.J., Hao X., Sylven C., Dellgren G. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann. Med. 2006, 38:144-153.
13. Hood B., Levene H.B., Levi A.D. Transplantation of autologous Schwann cells for the repair of segmental peripheral nerve defects. Neurosurg. Focus 2009, 26:E4.
14. Hu J., Zhu Q.T., Liu X.L., Xu Y.B., Zhu J.K. Repair of extended peripheral nerve lesions in rhesus monkeys using acellular allogenic nerve grafts implanted with autologous mesenchymal stem cells. Exp. Neurol. 2007, 204:658-666.
15. Ibarra A., Hernandez E., Lomeli J., Pineda D., Buenrostro M., Martinon S., Garcia E., Flores N., Guizar-Sahagun G., Correa D., Madrazo I. Cyclosporin-A enhances non-functional axonal growing after complete spinal cord transection. Brain Res. 2007, 1149:200-209.
16. Kalbermatten D.F., Kingham P.J., Mahay D., Mantovani C., Pettersson J., Raffoul W., Balcin H., Pierer G., Terenghi G. Fibrin matrix for suspension of regenerative cells in an artificial nerve conduit. J. Plast. Reconstr. Aesthet. Surg. 2008, 61:669-675.
17. Kalbermatten D.F., Pettersson J., Kingham P.J., Pierer G., Wiberg M., Terenghi G. New fibrin conduit for peripheral nerve repair. J. Reconstr. Microsurg. 2009, 27-33.
18. Madduri S., Gander B. Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J. Peripher. Nerv. Syst. 2010, 15:93-103.
19. Matsuse D., Kitada M., Kohama M., Nishikawa K., Makinoshima H., Wakao S., Fujiyoshi Y., Heike T., Nakahata T., Akutsu H., Umezawa A., Harigae H., Kira J., Dezawa M. Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J. Neuropathol. Exp. Neurol. 2010, 69:973-985.
20. Matsushima Y., Baba T. The in vivo effect of cyclosporine A on macrophages. J. Exp. Pathol. 1990, 39-48.
21. McGrath A.M., Novikova L.N., Novikov L.N., Wiberg M. BD PuraMatrix peptide hydrogel seeded with Schwann cells for peripheral nerve regeneration. Brain Res. Bull. 2010, 83:207-213.
22. Mosahebi A., Woodward B., Wiberg M., Martin R., Terenghi G. Retroviral labeling of Schwann cells: in vitro characterization and in vivo transplantation to improve peripheral nerve regeneration. Glia 2001, 34:8-17.
23. Pabari A., Yang S.Y., Mosahebi A., Seifalian A.M. Recent advances in artificial nerve conduit design: strategies for the delivery of luminal fillers. J. Control. Release 2011.
24. Pan H.C., Yang D.Y., Chiu Y.T., Lai S.Z., Wang Y.C., Chang M.H., Cheng F.C. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J. Clin. Neurosci. 2006, 13:570-575.
25. Pettersson J., Kalbermatten D., McGrath A., Novikova L.N. Biodegradable fibrin conduit promotes long-term regeneration after peripheral nerve injury in adult rats. J. Plast. Reconstr. Aesthet. Surg. 2010, 63:1893-1899.
26. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
27. Scholz T., Sumarto A., Krichevsky A., Evans G.R. Neuronal differentiation of human adipose tissue-derived stem cells for peripheral nerve regeneration in vivo. Arch. Surg. 2011, 146:666-674.
28. Shimizu S., Kitada M., Ishikawa H., Itokazu Y., Wakao S., Dezawa M. Peripheral nerve regeneration by the in vitro differentiated-human bone marrow stromal cells with Schwann cell property. Biochem. Biophys. Res. Commun. 2007, 359:915-920.
29. Sosa I., Reyes O., Kuffler D.P. Immunosuppressants: neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions. Exp. Neurol. 2005, 195:7-15.
30. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., Snyder S.H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 1997, 3:421-428.
31. Strittmatter S.M., Vartanian T., Fishman M.C. GAP-43 as a plasticity protein in neuronal form and repair. J. Neurobiol. 1992, 23:507-520.
32. Sugawara T., Itoh Y., Mizoi K. Immunosuppressants promote adult dorsal root regeneration into the spinal cord. Neuroreport 1999, 10:3949-3953.
33. Ussia G., Cuccomarino S., Ravo B., Galletti G. Combined laparoendoscopic colon resection and anastomosis using the no touch technique and fibrin glue. An experimental study. Surg. Endosc. 1998, 1046-1050.
34. Wakao S., Hayashi T., Kitada M., Kohama M., Matsue D., Teramoto N., Ose T., Itokazu Y., Koshino K., Watabe H., Iida H., Takamoto T., Tabata Y., Dezawa M. Long-term observation of auto-cell transplantation in non-human primate reveals safety and efficiency of bone marrow stromal cell-derived Schwann cells in peripheral nerve regeneration. Exp. Neurol. 2010, 223:537-547.
35. Walsh S., Midha R. Use of stem cells to augment nerve injury repair. Neurosurgery 2009, 65:A80-A86.
36. Wang D., Liu X.L., Zhu J.K., Jiang L., Hu J., Zhang Y., Yang L.M., Wang H.G., Yi J.H. Bridging small-gap peripheral nerve defects using acellular nerve allograft implanted with autologous bone marrow stromal cells in primates. Brain Res. 2008, 1188:44-53.
37. Wiberg M., Terenghi G. Will it be possible to produce peripheral nerves?. Surg. Technol. Int. 2003, 11:303-310.